Hanne Grøn

Title: Hanne Grønn: Innovator in Immune Response Modulation

Introduction

Hanne Grønn is a notable inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of immunology through her innovative research and patent work. Her expertise lies in the development of immune response modulators, which have the potential to enhance vaccine efficacy.

Latest Patents

Hanne Grønn holds a patent for an "Immune response modulator alpha-2 macroglobulin complex." This invention involves the activation of α-macroglobulin (α M) with a nucleophilic compound, followed by incubation at elevated temperatures with a biomolecule. This process results in the covalent incorporation of the intact biomolecule into the α M molecule, without the use of proteinases. The resulting structurally defined and stable complex can be utilized as an antigen for stimulating the immune response, particularly in vaccine development. This innovation enhances antigen presentation, especially for biomolecules that are poorly immunogenic, and reduces the immunodominance of specific epitopes.

Career Highlights

Hanne Grønn is affiliated with Duke University, where she conducts her research and collaborates with other experts in the field. Her work has garnered attention for its potential applications in vaccine development and immune response enhancement.

Collaborations

Hanne collaborates with Salvatore Pizzo, who is also involved in research related to immune response modulation. Their partnership exemplifies the collaborative spirit of scientific research, leading to advancements in immunology.

Conclusion

Hanne Grønn's contributions to the field of immunology through her innovative patent work highlight her role as a leading inventor. Her research has the potential to significantly impact vaccine development and immune response modulation.